Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

Fat isn’t just a guilty pleasure — it’s cancer’s secret weapon. New research from UT Southwestern Medical Center is shedding light on why this is the case.In a study published this month in the ...

Outcomes of first-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC). Authors: Chun Loo Gan, ...

The proper frequency of these blood tests depends on your age and personal health status -- the most important thing is to ...

Background Classification and treatment decisions in lupus nephritis (LN) are largely based on renal histology. Single-cell RNA sequencing (scRNAseq) analysis may accurately differentiate types of ...

New research by Sumeda Nandadasa, Ph.D., reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...

Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic ...

Department of Nephrology, The Second Hospital of Zhuzhou City, Zhuzhou, Hunan, China The endoplasmic reticulum (ER) is the most metabolically active organelle in cells, and recent research has shown ...

Idiopathic nephrotic syndrome (INS) is a serious kidney disease in children with no clear cause. In a recent study, researchers have identified a novel autoantibody targeting vinculin—a protein ...

About 3,500 Illinoisans are waiting for a kidney transplant in Illinois, where, according to the American Kidney Fund, the average wait time is five to seven years.